Back to Capital Research Global Investors Capital Research Global Investors

CNMDCNMD
Showing 8 of 31 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in CONMED CORP

Yes. Capital Research Global Investors holds 823,636 shares of CNMD (Conmed), worth $27M, as of its Q2 2026 13F filing. It reduced the position by 101,812 shares (-11.0%) from Q1 2026. Capital Research Global Investors has held CNMD in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$27M

Current Shares

823,636

Total Value Change

-$84.1M

Total Shares Change

-720,906

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
823,636
-11.0%
$27M0.0%$32.73
0
2026-Q1
Unchanged
925,448
0.0%
$32.7M0.0%$35.36
0
2025-Q4
Decreased
925,448
-10.4%
$37.6M0.0%$40.60
0
2025-Q3
Decreased
1M
-38.4%
$48.6M0.0%$47.03
0
2025-Q2
Increased
1.7M
+0.2%
$87.3M0.0%$51.88
30
2025-Q1
Increased
1.7M
+6.1%
$101.1M0.0%$59.94
32
2024-Q4
Increased
1.6M
+2.1%
$107.9M0.0%$67.70
31
2024-Q3
Decreased
1.5M
-9.7%
$111.1M0.0%$70.94
0

Other major holders of CNMD: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used